Susquehanna International Group, LLP Scynexis Inc Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Scynexis Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 58,728 shares of SCYX stock, worth $48,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,728
Previous 30,420
93.06%
Holding current value
$48,744
Previous $28,000
39.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SCYX
# of Institutions
45Shares Held
11.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.4 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.86 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.38 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.02 Million0.22% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$461,1100.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $27.1M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...